Imidazole derivatives as kinesin spindle protein inhibitors (Eg-5)

Details for Australian Patent Application No. 2008205169 (hide)

Owner Novartis AG

Inventors Wang, Weibo; Martin, Eric; Boyce, Rustum; Barsanti, Paul A.; Yang, Hong

Agent Davies Collison Cave

Pub. Number AU-B-2008205169

PCT Pub. Number WO2008/086122

Priority 60/883,740 05.01.07 US

Filing date 3 January 2008

Wipo publication date 17 July 2008

Acceptance publication date 2 February 2012

International Classifications

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/086122 Priority application(s): WO2008/086122

2 February 2012 Application Accepted

  Published as AU-B-2008205169

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008205213-Method of inserting promotional content within downloaded video content

2008205164-Authorable content rating system